Index
1 Market Overview of Plasma Therapeutics
1.1 Plasma Therapeutics Market Overview
1.1.1 Plasma Therapeutics Product Scope
1.1.2 Plasma Therapeutics Market Status and Outlook
1.2 Global Plasma Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Plasma Therapeutics Market Size by Region (2018-2029)
1.4 Global Plasma Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Plasma Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Plasma Therapeutics Market Size (2018-2029)
1.6.1 North America Plasma Therapeutics Market Size (2018-2029)
1.6.2 Europe Plasma Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Plasma Therapeutics Market Size (2018-2029)
1.6.4 Latin America Plasma Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Plasma Therapeutics Market Size (2018-2029)
2 Plasma Therapeutics Market by Type
2.1 Introduction
2.1.1 Human Serum Protein
2.1.2 Plasma-Derived Clotting Factor
2.1.3 Immunoglobulins
2.1.4 High Immunoglobulins
2.2 Global Plasma Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Plasma Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Plasma Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Plasma Therapeutics Revenue Breakdown by Type (2018-2029)
3 Plasma Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Research Laboratories And Institutions
3.1.2 Hospitals
3.1.3 Stand-Alone Blood Banks
3.2 Global Plasma Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Plasma Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Plasma Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Plasma Therapeutics Revenue Breakdown by Application (2018-2029)
4 Plasma Therapeutics Competition Analysis by Players
4.1 Global Plasma Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Therapeutics as of 2022)
4.3 Date of Key Players Enter into Plasma Therapeutics Market
4.4 Global Top Players Plasma Therapeutics Headquarters and Area Served
4.5 Key Players Plasma Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Plasma Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Baxter
5.1.1 Baxter Profile
5.1.2 Baxter Main Business
5.1.3 Baxter Plasma Therapeutics Products, Services and Solutions
5.1.4 Baxter Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Baxter Recent Developments
5.2 CSL Behring
5.2.1 CSL Behring Profile
5.2.2 CSL Behring Main Business
5.2.3 CSL Behring Plasma Therapeutics Products, Services and Solutions
5.2.4 CSL Behring Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 CSL Behring Recent Developments
5.3 Grifols Therapeutics
5.3.1 Grifols Therapeutics Profile
5.3.2 Grifols Therapeutics Main Business
5.3.3 Grifols Therapeutics Plasma Therapeutics Products, Services and Solutions
5.3.4 Grifols Therapeutics Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Octapharma Recent Developments
5.4 Octapharma
5.4.1 Octapharma Profile
5.4.2 Octapharma Main Business
5.4.3 Octapharma Plasma Therapeutics Products, Services and Solutions
5.4.4 Octapharma Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Octapharma Recent Developments
5.5 Abeona Therapeutics
5.5.1 Abeona Therapeutics Profile
5.5.2 Abeona Therapeutics Main Business
5.5.3 Abeona Therapeutics Plasma Therapeutics Products, Services and Solutions
5.5.4 Abeona Therapeutics Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Abeona Therapeutics Recent Developments
5.6 ADMA Biologics
5.6.1 ADMA Biologics Profile
5.6.2 ADMA Biologics Main Business
5.6.3 ADMA Biologics Plasma Therapeutics Products, Services and Solutions
5.6.4 ADMA Biologics Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 ADMA Biologics Recent Developments
5.7 Amag Pharmaceuticals
5.7.1 Amag Pharmaceuticals Profile
5.7.2 Amag Pharmaceuticals Main Business
5.7.3 Amag Pharmaceuticals Plasma Therapeutics Products, Services and Solutions
5.7.4 Amag Pharmaceuticals Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Amag Pharmaceuticals Recent Developments
5.8 Antares Pharma
5.8.1 Antares Pharma Profile
5.8.2 Antares Pharma Main Business
5.8.3 Antares Pharma Plasma Therapeutics Products, Services and Solutions
5.8.4 Antares Pharma Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Antares Pharma Recent Developments
5.9 BioDelivery Sciences
5.9.1 BioDelivery Sciences Profile
5.9.2 BioDelivery Sciences Main Business
5.9.3 BioDelivery Sciences Plasma Therapeutics Products, Services and Solutions
5.9.4 BioDelivery Sciences Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 BioDelivery Sciences Recent Developments
5.10 Bio Products Laboratory
5.10.1 Bio Products Laboratory Profile
5.10.2 Bio Products Laboratory Main Business
5.10.3 Bio Products Laboratory Plasma Therapeutics Products, Services and Solutions
5.10.4 Bio Products Laboratory Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Bio Products Laboratory Recent Developments
5.11 Biota Pharmaceuticals
5.11.1 Biota Pharmaceuticals Profile
5.11.2 Biota Pharmaceuticals Main Business
5.11.3 Biota Pharmaceuticals Plasma Therapeutics Products, Services and Solutions
5.11.4 Biota Pharmaceuticals Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Biota Pharmaceuticals Recent Developments
5.12 Biotest Pharmaceuticals
5.12.1 Biotest Pharmaceuticals Profile
5.12.2 Biotest Pharmaceuticals Main Business
5.12.3 Biotest Pharmaceuticals Plasma Therapeutics Products, Services and Solutions
5.12.4 Biotest Pharmaceuticals Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Biotest Pharmaceuticals Recent Developments
5.13 China Biologic Products
5.13.1 China Biologic Products Profile
5.13.2 China Biologic Products Main Business
5.13.3 China Biologic Products Plasma Therapeutics Products, Services and Solutions
5.13.4 China Biologic Products Plasma Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 China Biologic Products Recent Developments
6 North America
6.1 North America Plasma Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Plasma Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Plasma Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Plasma Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Plasma Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Plasma Therapeutics Market Dynamics
11.1 Plasma Therapeutics Industry Trends
11.2 Plasma Therapeutics Market Drivers
11.3 Plasma Therapeutics Market Challenges
11.4 Plasma Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List